First Time Loading...

Fulcrum Therapeutics Inc
NASDAQ:FULC

Watchlist Manager
Fulcrum Therapeutics Inc Logo
Fulcrum Therapeutics Inc
NASDAQ:FULC
Watchlist
Price: 7.33 USD 2.81% Market Closed
Updated: May 2, 2024

Fulcrum Therapeutics Inc
Cash from Investing Activities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Fulcrum Therapeutics Inc
Cash from Investing Activities Peer Comparison

Comparables:
JNJ
BMY
PFE
MRK
LLY

Competitive Cash from Investing Activities Analysis
Latest Figures & CAGR of Competitors

Company Cash from Investing Activities CAGR 3Y CAGR 5Y CAGR 10Y
Fulcrum Therapeutics Inc
NASDAQ:FULC
Cash from Investing Activities
-$36.7m
CAGR 3-Years
14%
CAGR 5-Years
-33%
CAGR 10-Years
N/A
Johnson & Johnson
NYSE:JNJ
Cash from Investing Activities
$878m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Bristol-Myers Squibb Co
NYSE:BMY
Cash from Investing Activities
-$21.7B
CAGR 3-Years
-23%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Pfizer Inc
NYSE:PFE
Cash from Investing Activities
-$32.3B
CAGR 3-Years
-96%
CAGR 5-Years
N/A
CAGR 10-Years
-12%
Merck & Co Inc
NYSE:MRK
Cash from Investing Activities
-$14.1B
CAGR 3-Years
-18%
CAGR 5-Years
N/A
CAGR 10-Years
-9%
Eli Lilly and Co
NYSE:LLY
Cash from Investing Activities
-$7.2B
CAGR 3-Years
-47%
CAGR 5-Years
N/A
CAGR 10-Years
-13%

See Also

What is Fulcrum Therapeutics Inc's Cash from Investing Activities?
Cash from Investing Activities
-36.7m USD

Based on the financial report for Dec 31, 2023, Fulcrum Therapeutics Inc's Cash from Investing Activities amounts to -36.7m USD.

What is Fulcrum Therapeutics Inc's Cash from Investing Activities growth rate?
Cash from Investing Activities CAGR 5Y
-33%

The average annual Cash from Investing Activities growth rates for Fulcrum Therapeutics Inc have been 14% over the past three years , -33% over the past five years .